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Systemic inflammation and family 
history in relation to the prevalence 
of type 2 diabetes based on an 
alternating decision tree
Hirokazu Uemura1,*, A. Ammar Ghaibeh2,*, Sakurako Katsuura-Kamano1, Miwa Yamaguchi1, 
Tirani Bahari1, Masashi Ishizu1, Hiroki Moriguchi2 & Kokichi Arisawa1
To investigate unknown patterns associated with type 2 diabetes in the Japanese population, we first 
used an alternating decision tree (ADTree) algorithm, a powerful classification algorithm from data 
mining, for the data from 1,102 subjects aged 35–69 years. On the basis of the investigated patterns, 
we then evaluated the associations of serum high-sensitivity C-reactive protein (hs-CRP) as a biomarker 
of systemic inflammation and family history of diabetes (negative, positive or unknown) with the 
prevalence of type 2 diabetes because their detailed associations have been scarcely reported. Elevated 
serum hs-CRP levels were proportionally associated with the increased prevalence of type 2 diabetes 
after adjusting for probable covariates, including body mass index and family history of diabetes  
(P for trend = 0.016). Stratified analyses revealed that elevated serum hs-CRP levels were proportionally 
associated with increased prevalence of diabetes in subjects without a family history of diabetes (P for 
trend = 0.020) but not in those with a family history or with an unknown family history of diabetes. 
Our study demonstrates that systemic inflammation was proportionally associated with increased 
prevalence of type 2 diabetes even after adjusting for body mass index, especially in subjects without a 
family history of diabetes.
The prevalence of type 2 diabetes has been increasing globally1. Obesity is a key risk factor for various chronic 
diseases, including type 2 diabetes2,3. A number of other risk factors have also been identified for type 2 diabetes. 
However, unknown factors or patterns may also affect the risk for type 2 diabetes. We have conducted a prospec-
tive cohort study since 2008 in Tokushima Prefecture, Japan. This cohort study has included considerable baseline 
data (about 240 variables) on medical history, family history of diseases, lifestyle characteristics, anthropometric 
measurements, and biochemical examinations4,5.
In the present study, we first generated a prediction model for the prevalence of type 2 diabetes in this baseline 
dataset using alternating decision tree (ADTree) algorithm6, a powerful classification algorithm for data mining. 
There has been a recent increase in the use of data mining methods in various aspects of medicine due to their 
promising results7–9. Data mining aims to extract useful information from available data by applying techniques 
from various fields including databases, machine learning, statistics, and visualization10.
The resulting ADTree in the present study indicated that having a positive or unknown family history of 
diabetes showed positive impact on the prevalence of type 2 diabetes; furthermore, in subjects without a fam-
ily history of diabetes, increased serum levels (≥ 0.26 mg/L) of high-sensitivity C-reactive protein (hs-CRP), a 
systemic inflammatory marker, showed positive impact on the prevalence of type 2 diabetes. Having a family 
history of diabetes is a well-recognized risk factor for developing type 2 diabetes11. Low-grade systemic inflam-
mation has also been reported to be associated with various diseases including type 2 diabetes12,13. However, the 
combined associations of family history of diabetes and systemic inflammation with type 2 diabetes have been 
scarcely reported, especially in the Japanese population. Therefore, we performed hypothesis testing and logistic 
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regression analyses in order to calculate the statistical significance and odds ratios of the factors identified by the 
ADTree.
Methods
Study subjects. This cross-sectional study included participants aged 35–69 years who participated in the 
baseline survey of a prospective cohort study from January 2008 to February 2013 in Tokushima Prefecture, 
Japan. This study was performed as part of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study. 
Details of this cohort study have been reported elsewhere14. In brief, the J-MICC Study aims to examine the asso-
ciations of lifestyle and genetic factors, as well as their interactions with lifestyle-related diseases.
The population in the present study consisted of two groups. The first group consisted of 570 participants who 
received health examinations at the Tokushima Prefectural General Health Check-up Center from January 2008 
to November 2011. The second group consisted of 696 participants who were general inhabitants of Tokushima 
city and neighboring towns and attended the health check-ups performed by our research team between July 
2012 and February 2013. Of the 1,266 participants (637 men and 629 women), 164 (81 men and 83 women) were 
excluded for the following reasons (overlapping): (1) previous history of ischemic heart disease (n = 29) and/
or stroke (n = 14); (2) missing data regarding fasting blood glucose (n = 9), diabetes treatment (n = 0), family 
history of diabetes (n = 14), or any potential confounding factors included in the multivariable-adjusted models 
(n = 31); (3) extremely high (> 4,000 kcal/day) or low (< 1,000 kcal/day) estimated daily energy intake (n = 11); 
and 4) missing serum hs-CRP values (n = 5) or values ≥ 10 mg/L (n = 15) (confirmed acute inflammatory status), 
history of rheumatoid arthritis (n = 4), which is accompanied by systemic inflammation, and/or regular use of 
anti-inflammatory analgesics (n = 48) that could affect serum hs-CRP values. The remaining 1,102 subjects (556 
men and 546 women) were included in the analyses.
All participants in the J-MICC Study provided written informed consent prior to participation. This study 
was conducted according to the principles of the Declaration of Helsinki, and the ethics committees of Nagoya 
University School of Medicine (the affiliation of the former principal investigator, Nobuyuki Hamajima), Aichi 
Cancer Center (the affiliation of the current principal investigator, Hideo Tanaka), and Tokushima University 
Graduate School all approved the protocol of the present study.
Questionnaire. All participants were requested to complete a structured self-administered questionnaire 
regarding lifestyle characteristics, including leisure-time exercise, smoking status, alcohol consumption, and die-
tary habits over the past year at the baseline survey, as described previously4,5,15. This questionnaire also included 
the questions about medical history and family history of diseases.
Leisure-time exercise was divided into three categories: light exercise such as walking or hiking, moderate 
exercise such as light jogging or swimming, and vigorous exercise such as marathon running or competitive 
sports, based on the intensity of the exercise: 3.4, 7.0, and 10.0 metabolic equivalents (METs), respectively. The 
amount of each exercise category was calculated by multiplying the frequency and duration of each exercise activ-
ity (MET level × hours per activity × activity frequency per week); these were summed to estimate the degree of 
leisure-time exercise and are expressed as MET-hours/week, as described previously15.
Dietary evaluations were conducted using a validated short food frequency questionnaire (FFQ)16–19. The 
FFQ included questions regarding the intake of 47 foods and beverages, listed in Fig. 1, over the previous year. 
Information concerning the intake frequency and amounts of the 3 staple foods (i.e., rice, bread, and noodles) 
consumed at breakfast, lunch, and dinner was obtained. The volume and frequency of the consumption of alco-
holic beverages including sake, beer, shochu (a Japanese distilled beverage), chuhai (a sweetened beverage mixed 
with shochu), whiskey, and wine, were determined. Only the intake frequency was obtained for the other 43 foods 
and beverages as follows (eight categories): three or more times/day (3/day), twice/day (2/day), once/day (1/day), 
5–6 times/week (0.8/day), 3–4 times/week (0.5/day), 1–2 times/week (0.2/day), 1–3 times/month (0.1/day), and 
never or seldom (0/day). Daily energy intake and carbohydrate intake were calculated using a program developed 
by the Department of Public Health, Nagoya City University School of Medicine16,17.
Additionally, medical history of diabetes (yes, no, or unknown) for each subject’s mother and father was 
obtained. When neither the mother nor father had a medical history of diabetes, the subjects was considered 
negative for a family history of diabetes; when either the mother or father had a medical history of diabetes, the 
subjects was considered positive for a family history of diabetes. In others cases, a family history of diabetes was 
regarded as unknown.
Measurements and diabetes assessment. Body height and weight were measured to the nearest 0.1 cm 
and 0.1 kg, respectively, at the time of health check-up. Body mass index (BMI) was calculated as weight (kg) 
divided by height (m) squared. Venous blood was drawn from each participant, and serum was separated within 
three hours. Fasting plasma glucose levels were obtained from the health check-up data, and hs-CRP levels in 
stored sera at − 80 °C were also measured at an external laboratory (BML Inc., Tokyo, Japan).
Diabetes was defined as a fasting plasma glucose level ≥ 126 mg/dL or as receiving diabetes treatment20.
Statistical analyses. Our data had a large imbalance; i.e. there were a fewer number of cases of type 2 dia-
betes compared to the number of non-cases. In such situations, standard data mining techniques such as decision 
trees usually fail to provide good results21,22. Setoguchi et al.23 used alternating decision trees in a highly skewed 
data set to predict the potential for developing pressure ulcers in in-hospital patients. We used a similar approach 
in our work. Decision trees are powerful classification methods that have been used successfully in many medical 
studies24 because they provide easily understandable graphical classification rules with good accuracy. However, 
decision trees and many other machine learning and statistical methods encounter difficulties when working 
with highly skewed and imbalanced data21. One solution is to apply a boosting algorithm25. Although boosting 
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can improve the performance of decision trees, it results in multiple trees and makes the results difficult to under-
stand. Freund et al.6 have developed an easy-to-understand decision tree that combines two-layer decision trees 
(decision stumps) and Adaptive Boosting (AdaBoost)26 to generate a single, easily understandable tree called 
ADTree. An ADTree consists of two kinds of nodes: decision nodes and prediction nodes, as shown in Fig. 2. 
It starts with a prediction node at its root, then alternates between decision nodes and prediction nodes until it 
finally terminates with prediction nodes. A decision node provides an inequality condition for one of the input 
factors (e.g. family history of diabetes) and followed by two prediction nodes correspond to each of the two pos-
sible inequality results (True or False). Each prediction node has a real value that indicates the contribution of 
the corresponding inequality result to the final classification (i.e. diagnosis). Depending on the inequality result 
further decision nodes might be added before we finally reach a terminal prediction node. The route from the root 
node to any of the terminal prediction nodes is usually referred to as a path where in general an instance can trav-
erse multiple paths. The final classification is determined by the sign of the summation of the values of all predic-
tion nodes that belong to all instance multiple paths. A positive sign indicates a positive class, and a negative sign 
indicates a negative class. The factors used in the decision node inequality are determined through a search pro-
cedure that look for the factor with best classification power. The ADTree was generated using RapidMiner Studio 
Ver. 7.2 (http://www.rapidminer.com), and was validated using 10-folds cross validation technique10. 10-folds 
cross validation is a low variance estimation method widely used in data mining. The data set is divided into 10 
subsets and the classification model is generated 10 times. During each run, one of the subsets is used for valida-
tion and the remaining 9 subsets combined are used for model generation. The average and standard deviation 
of the 10 validations are reported. The generated ADTree’s accuracy, sensitivity, and specificity were 69.6 ± 5.2%, 
Figure 1. List of the foods and beverages included in the food frequency questionnaire (FFQ). 
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72.3 ± 22.4%, and 69.4 ± 6.2%, respectively. The ADTree showed that having a positive or an unknown family 
history of diabetes was related to increased prevalence of type 2 diabetes; within the group of subjects without 
a family history of diabetes, elevated serum hs-CRP level was related to increased prevalence of type 2 diabetes 
(shown in Fig. 3). To calculate the statistical importance of each factor in the ADTree, we performed logistic 
regression analyses. In these analyses, family history of diabetes was divided into two categories according to the 
ADTree; “negative” and “positive or unknown”. The prevalence rates of diabetes according to “negative”, “positive”, 
and “unknown” status were 3.2%, 9.2%, and 8.3%, respectively.
Continuous variables were expressed as means ± SD or medians (25th percentile, 75th percentile). Categorical 
variables were expressed as the number (%). Two sample t-test, Wilcoxon rank sum test, or chi-square tests were 
used to compare the baseline characteristics between subjects having negative and positive/unknown family his-
tory of diabetes as appropriate. Logistic regression analyses were performed to evaluate the associations between 
serum hs-CRP levels and the prevalence of type 2 diabetes after adjusting for the following covariates: (1) age 
(continuous) and sex (model 1); (2) age, sex, recruitment group (binary), smoking status (current, past, and 
never), current alcohol drinking (no, yes), leisure-time exercise (MET-hours/week; quartiles), daily carbohydrate 
intake (g/day; continuous), and daily energy intake (kcal/day; continuous) (model 2); (3) the covariates in model 
2 plus BMI (kg/m2; quartiles) (model 3); and (4) the covariates in model 3 plus family history of diabetes (nega-
tive; positive or unknown) (model 4).
We also evaluated the combined associations of serum hs-CRP level (≤ median, > median) and family history 
of diabetes (negative, positive or unknown) with the prevalence of diabetes by similar logistic regression analy-
ses. The effects of the interactions between serum hs-CRP level and family history of diabetes on the prevalence 
of diabetes were evaluated by including interaction terms in the models. We further evaluated the associations 
between serum hs-CRP level (three categories: first plus second quartiles, third quartile, and fourth quartile in all 
subjects) and the prevalence of diabetes stratified by family history of diabetes. In this stratified analysis, in addi-
tion to the strata of negative and positive/unknown family history, the stratum of positive family history alone 
(excluding unknown family history) was also evaluated, and stratum-specific quartiles of leisure-time exercise 
and BMI were included in the models.
All calculations and statistical tests were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA). 
All statistical tests were based on 2-sided probabilities, with a significance level of P < 0.05.
Results
As shown in the resulting ADTree in Fig. 3, having a positive or unknown family history of diabetes showed 
positive impact on the prevalence of type 2 diabetes; in addition, within the group of subjects without a family 
history of diabetes, elevated serum hs-CRP levels (≥ 0.26 mg/L) showed positive impact on the prevalence of type 
2 diabetes.
Baseline characteristics of the subjects according to family history of diabetes. Table 1 shows 
the baseline characteristics of the subjects according to their family history of diabetes. The prevalence of diabetes 
was significantly higher (8.8%) in subjects positive for or with an unknown family history of diabetes than that 
(3.2%) in subjects without a family history of diabetes. Subjects positive for or with an unknown family history 
of diabetes were older and had a lower level of leisure-time exercise compared to those without a history. Energy 
intake and the distributions of recruitment groups, gender, smoking habit, and alcohol drinking did not differ 
between the two groups.
Figure 2. An alternating decision tree (ADTree) structure and prediction method. A case with the following 
conditions (Condition 1 = True, Condition 2 = True, Condition 3 = True, Condition 4 = False, Condition 
5 = True) will be associated with the multi-path with bold solid line. Its diagnosis prediction = sign (0.6 + 0.4–
0.3 + 1.2–1.6) = sign (+ 0.3). This positive sign (+ 0.3) means positive association with a setting outcome.
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Associations between serum hs-CRP levels and the prevalence of type 2 diabetes. Table 2 pre-
sents the associations between serum hs-CRP level and the prevalence of diabetes. Elevated serum hs-CRP level 
was proportionally associated with increased prevalence of diabetes after adjusting for probable covariates (P for 
trend was < 0.001 in model 2). After additionally adjusting for BMI (model 3), the association remained signifi-
cant, although it was slightly attenuated (P for trend was 0.015). Further adjusting for family history of diabetes 
did not change the association observed in model 3 (P for trend was 0.016 in model 4).
Figure 3. Result of the alternating decision tree (ADTree) for the prevalence of type 2 diabetes. The ADTree 
indicates that having a positive or unknown family history of diabetes has positive impact and not having a 
family history has negative impact on the prevalence of type 2 diabetes. In addition, within the group of subjects 
without a family history of diabetes, elevated serum hs-CRP (≥ 0.26 mg/L) levels have positive impact on the 
prevalence of type 2 diabetes, while serum hs-CRP levels < 0.26 mg/L have negative impact. GGT, gamma-
glutamyl transferase; hs-CRP, high-sensitivity C-reactive protein.
Family history of diabetes
Negative Positive/Unknown
P(n = 626) (n = 476)
Genderc
 Men 319 (51.0) 237 (49.8)
0.701
 Women 307 (49.0) 239 (50.2)
Recruit groupc
 Health Check-up Center 295 (47.1) 218 (45.8)
0.662
 Participants by leaflet 331 (52.9) 258 (54.2)
Age (years)a 52.0 ± 9.9 53.6 ± 9.5 0.009
BMI (kg/m2)b 22.8 (21.0, 25.2) 23.1 (21.0, 25.8) 0.078
Smoking statusc
 Current 94 (15.0) 83 (17.4)
0.521 Past 162 (25.9) 124 (26.1)
 Never 370 (59.1) 269 (56.5)
Alcohol drinkingc
 Current 345 (55.1) 261 (54.8)
0.716 Past 8 (1.3) 9 (1.9)
 Never 273 (43.6) 206 (43.3)
Leisure-time exercise (MET-hours/week)b 7.65 (1.28, 23.10) 5.10 (1.28, 17.85) 0.046
Carbohydrate intake (g/day)b 234 (198, 278) 233 (195, 274) 0.712
Energy intake (kcal/day)b 1677 (1490, 1904) 1660 (1471, 1862) 0.274
Serum hs-CRP (mg/L)b 0.30 (0.15, 0.61) 0.32 (0.16, 0.70) 0.316
Fasting plasma glucose (mg/dL)b 92 (87, 99) 93 (88, 101) 0.022
Diabetes prevalencec 20 (3.2) 42 (8.8) < 0.001
Table 1.  Clinical characteristics of the subjects according to their family history of diabetes. aMean ± SD, 
bMedian (25%, 75%), cNumber (%). BMI, body mass index; MET, metabolic equivalent; hs-CRP, high-sensitivity 
C-reactive protein. Differences are analyzed by t-test a, Wilcoxon rank sum test b, or chi-square test c.
www.nature.com/scientificreports/
6Scientific RepoRts | 7:45502 | DOI: 10.1038/srep45502
Combined associations of family history of diabetes and serum hs-CRP level with the preva-
lence of diabetes. As shown in Table 3, compared to the subjects in the reference group (not having a family 
history of diabetes and having lower hs-CRP level [≤ median]), subjects positive for or with an unknown family 
history of diabetes and lower hs-CRP level as well as those without a family history and with higher hs-CRP levels 
(> median) showed significantly high multivariable-adjusted odds ratios of 9.7 (2.6–63.0) and 6.2 (1.7–40.3), 
respectively, for the prevalence of diabetes (model 3). Having a positive or unknown family history and higher 
hs-CRP level resulted in a significantly high adjusted odds ratio of 12.5 (3.5–80.0) for the prevalence of diabetes; 
however, these impacts were not multiplicative, and the interaction effect between family history of diabetes and 
serum hs-CRP level on the prevalence of diabetes was significant (P for interaction was 0.039 in model 3).
Associations between serum hs-CRP level and the prevalence of diabetes stratified by family 
history of diabetes. Stratified analyses revealed that elevated serum hs-CRP level was proportionally and 
significantly associated with an increased prevalence of type 2 diabetes in subjects without a family history of 
diabetes (P for trend was 0.020), but not in those positive for or with an unknown family history nor in those with 
a family history (Table 4).
Discussion
The current study utilizing ADTree algorithm, a powerful classification algorithm for data mining (machine 
learning), and traditional statistical analyses (logistic regression analyses) revealed that elevated serum hs-CRP 
level, a systemic inflammation biomarker, was proportionally associated with an increased prevalence of type 2 
diabetes after adjusting for traditional risk factors including BMI in the Japanese population. The impact of ele-
vated serum hs-CRP level on the prevalence of type 2 diabetes was prominent in subjects without a family history 
of diabetes.
Serum hs-CRP
P for trend
Q1 + Q2 (≤0.31 mg/L) Q3 (>0.31∼0.66 mg/L) Q4 (>0.66 mg/L)
OR (95% CI) OR (95% CI) OR (95% CI)
Prevalence rate of diabetes (%) 3.0 6.4 10.2
Model 1 1 1.7 (0.86, 3.5) 3.0 (1.6, 5.7) < 0.001
Model 2 1 1.9 (0.91, 3.8) 3.2 (1.7, 6.3) < 0.001
Model 3 1 1.5 (0.68, 3.1) 2.4 (1.2, 4.8) 0.015
Model 4 1 1.5 (0.71, 3.3) 2.4 (1.2, 4.9) 0.016
Table 2.  Associations between serum hs-CRP and the prevalence of type 2 diabetes. hs-CRP, high-
sensitivity C-reactive protein; Q2, first quartile; Q3, second quartile; Q4, third quartile; Q1, fourth quartile. OR, 
odds ratio; CI, confidence interval. Model 1: adjusted for age and sex. Model 2: adjusted for age, sex, recruit 
group, smoking status, current alcohol drinkings, leisure-time exercise, carbohydrate intake, and energy intake. 
Model 3: adjusted for the covariates in model 2 plus body mass index. Model 4: adjusted for the covariates in 
model 3 plus family history of diabetes.
Serum hs-CRP
Family history of diabetes
Negative Positive/Unknown
OR (95% CI) OR (95% CI)
Model 1
 ≤ Median 1 10.1 (2.8–64.6)
 > Median 8.2 (2.3–51.8) 15.5 (4.5–97.4)
 *Pinteraction 0.023
Model 2
 ≤ Median 1 9.8 (2.7–63.2)
 > Median 8.5 (2.4–54.1) 17.2 (5.0–108.5)
 *Pinteraction 0.035
Model 3
 ≤ Median 1 9.7 (2.6–63.0)
 > Median 6.2 (1.7–40.3) 12.5 (3.5–80.0)
 *Pinteraction 0.039
Table 3. Combined associations of family history of diabetes and serum hs-CRP with the prevalence 
of type 2 diabetes. hs-CRP, high-sensitivity C-reactive protein; OR, odds ratio; CI, confidence interval. The 
median value of hs-CRP was 0.31 mg/L. Model 1: adjusted for age and sex. Model 2: adjusted for age, sex, recruit 
group, smoking status, current alcohol drinking, leisure-time exercise, carbohydrate intake, and energy intake. 
Model 3: adjusted for the covariates in model 2 plus body mass index. *P values for interaction of family history 
of diabetes (no, yes) and serum hs-CRP (≤ median, > median).
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The prevalence of type 2 diabetes has been rapidly increasing, which has become major worldwide public 
health and economic problems27,28. Therefore, it is essential to identify the risk and contributing factors of type 
2 diabetes in order to develop preventative measures. Most lifestyle-related diseases, including type 2 diabetes, 
are multifactorial. Various genetic, lifestyle and environmental risk factors have been identified, including family 
history due to the similarity in heredity and lifestyles11. As presented in the resulting ADTree in the present study, 
having a positive or unknown family history of diabetes, elevated serum gamma-glutamyl transferase, and suffer-
ing from hypertension showed positive impact on the prevalence of type 2 diabetes; these findings are concordant 
with previous reports11,29,30. Systemic inflammation has also been identified as playing a role in the pathogenesis 
of various diseases including type 2 diabetes12,13. CRP is produced by the liver in response to inflammation in 
the body and is a sensitive systemic biomarker of inflammation31. Fibrinogen and hs-CRP are the inflammatory 
markers most extensively studied for their relation to cardiovascular risk. As for the relation to diabetes, hs-CRP 
is most frequently studied, and hs-CRP measurement has recently become popular in clinical and health exami-
nation settings for assessing low-grade systemic inflammation. Therefore, we used serum hs-CRP as a biomarker 
of systemic inflammation in the present study. Although a number of studies have reported independent relation-
ships between some inflammatory markers, such as CRP and interleukin (IL)-6, and the risk of developing type 
2 diabetes12,13,32,33, conclusions about their independent associations have not been consistent between studies. 
Some studies, including a meta-analysis, have reported no associations after adjusting for adiposity such as BMI 
or waist circumference and have demonstrated that CRP may not be an independent risk factor for developing 
type 2 diabetes34,35.
The combined associations of family history of diabetes and systemic chronic inflammation with the prev-
alence of type 2 diabetes, investigated by applying a powerful algorithm called ADTree6, have been scarcely 
reported in the Japanese population. Therefore, the present study evaluated the associations of family history 
of diabetes and serum hs-CRP level with the prevalence of type 2 diabetes in the Japanese population using 
cross-sectional data. We observed that elevated serum hs-CRP level was significantly and proportionally asso-
ciated with an increased prevalence of diabetes (P for trend was < 0.001) after adjusting for probable covariates 
(model 2). Additional adjustment for BMI (model 3) slightly attenuated this association, but it remained signif-
icant. Chronic inflammation level is elevated in obese subjects; serum hs-CRP level was significantly correlated 
with BMI in our subjects, but this correlation was not so strong (gender-adjusted partial correlation coefficient 
= 0.256, P < 0.001) (data not shown). Therefore, we believe that the relationship between elevated serum hs-CRP 
level and increased prevalence of type 2 diabetes may be explained in part by increased BMI; however, other 
mechanisms likely contribute to this relationship. Combined analyses (Table 3) revealed that having a positive or 
unknown family history of diabetes was highly associated with increased prevalence of diabetes in each serum 
hs-CRP level (≤ median and > median) and elevated serum hs-CRP level (> median) was also associated with 
increased prevalence of diabetes in both subjects without a family history of diabetes and those having a positive 
or unknown family history. The cut-off value of 0.31 mg/L (median) was nearly equal to that (0.26 mg/L) indi-
cated by ADTree (Fig. 3). Stratified analyses (Table 4) revealed that elevated serum hs-CRP level was proportion-
ally and intensely associated with an increased prevalence of diabetes among subjects without a family history 
of diabetes. Although having a family history and elevated systemic inflammation are independently associated 
with the prevalence of diabetes each other, the impact of systemic inflammation on diabetes might be obvious in 
subjects without a family history of diabetes.
Serum hs-CRP
Family history of diabetes
Negative (n = 626) Positive/Unknown (n = 476) Positive only (n = 271)
OR (95% CI) OR (95% CI) OR (95% CI)
Model 1
 Q1 + Q2 1 1 1
 Q3 7.3 (1.8–48.9) 1.0 (0.40–2.4) 1.2 (0.33–4.1)
 Q4 10.2 (2.6–67.2) 2.0 (0.92–4.2) 1.5 (0.56–4.3)
 P for trend 0.002 0.086 0.401
Model 2
 Q1 + Q2 1 1 1
 Q3 7.5 (1.8–50.8) 1.1 (0.44–2.8) 1.1 (0.28–4.0)
 Q4 12.1 (3.0–80.6) 2.2 (0.99–4.8) 1.7 (0.55–5.1)
 P for trend < 0.001 0.056 0.372
Model 3
 Q1 + Q2 1 1 1
 Q3 6.0 (1.4–42.5) 0.84 (0.30–2.2) 0.85 (0.18–3.6)
 Q4 7.1 (1.6–50.0) 1.7 (0.70–4.0) 1.3 (0.36–5.0)
 P for trend 0.020 0.218 0.632
Table 4. Associations of serum hs-CRP with the prevalence of diabetes stratified by family history of 
diabetes. hs-CRP, high-sensitivity C-reactive protein; Q1, first quartile; Q2, second quartile; Q3, third quartile; 
Q4, fourth quartile. OR, odds ratio; CI, confidence interval. Model 1: adjusted for age and sex. Model 2: adjusted 
for age, sex, recruit group, smoking status, current alcohol drinking, leisure-time exercise, carbohydrate intake, 
and energy intake. Model 3: adjusted for the covariates in model 2 plus body mass index.
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The mechanisms underlying the relationships between elevated serum hs-CRP level and increased preva-
lence of type 2 diabetes cannot be entirely understood, however, there are several plausible mechanisms. Human 
CRP plays an active role in inducing hepatic insulin resistance in rats, partially by activating extracellular 
signal-regulated kinase (ERK), with downstream impairment in the insulin signaling pathway36. Tumor necrosis 
factor alpha (TNF-α ) and interleukin-6 (IL-6), which are pro-inflammatory cytokines secreted by adipose tissue, 
can stimulate CRP production in the liver37. TNF-α is also known to induce insulin resistance38. A mouse study 
reported that chronic exposure to IL-6 inhibits insulin receptor signal transduction in primary hepatocytes39. The 
relationship between elevated serum hs-CRP level and glucose metabolism disorders may be intermediated by 
increased secretion of TNF-α and IL-6. Further studies enhancing and attenuating CRP function or production 
are necessary to determine the causal effects of CRP on glucose metabolism.
This study has several limitations. First, because of the cross-sectional study design, the causal relation-
ship between serum hs-CRP and the prevalence of type 2 diabetes should be interpreted with caution. Second, 
although the analyses adjusted for a number of potential confounding factors, residual confounding by unmeas-
ured genetic, lifestyle, or environmental factors cannot be eliminated. Third, information about family history of 
diabetes and other lifestyle factors was self-reported; therefore, non-differential misclassification may have been 
inevitable. Finally, since all of our subjects were Japanese, our results may not be generalizable in other ethnic 
populations. Despite these limitations, we consider our results to be meaningful for the prevention of type 2 dia-
betes. Measuring hs-CRP level is now convenient and popular in health examination and may be useful for the 
identification of individuals in the Japanese population at high risk of type 2 diabetes, especially those without a 
family history of diabetes.
In conclusion, our study demonstrates that systemic inflammation as measured by serum hs-CRP was pro-
portionally associated with an increased prevalence of type 2 diabetes after adjusting for BMI in the Japanese 
population, especially in subjects without a family history of diabetes. Further larger and prospective studies are 
necessary to confirm these associations and causality between serum hs-CRP level and type 2 diabetes.
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